Bulk anti-HLA-A2,B7 In Vivo Antibody – Low Endotoxin (BB7.6)
ichorbio’s anti-HLA-A2,B7 In Vivo Antibody – Low Endotoxin (BB7.6) is manufactured in a cGMP compliant, ISO Quality Standard 9001:2015 facility. ichorbio’s low endotoxin antibodies have half the endotoxin of comparable antibodies from our competitors at less than 1.0 EU/mg. If ichorbio’s low endotoxin antibodies are not low enough we also offer ultra low endotoxin antibodies which have even less endotoxin (<0.75EU/mg) at an even higher purity (98% versus 95%). ichorbio offers Amazon vouchers or donations to the NC3Rs for reviews of this product: click here for more information. ichorbio: the best antibodies for in vivo research.
Anti-HLA-A2,B7 In Vivo Antibody – Low Endotoxin (BB7.6) recognizes an epitope on Human HLA-A2,B7 (Note: Hundreds of HLA-A alleles have been described) This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Class I molecules play a central role in the immune system and are expressed in nearly all cells
Solubilized HLA-B7 antigen.
≥ 2.0 mg/ml
0.01 M phosphate buffered saline (PBS) pH 7.2, 150 mM NaCl with no carrier protein, potassium or preservatives added. BSA and Azide free.
>90% by SDS-PAGE and HPLC
>98% by SDS-PAGE and HPLC
≤ 1.0 EU/mg as determined by the LAL method
≤ 0.75 EU/mg as determined by the LAL method
Aggregation level ≤ 5%
Aggregation level ≤ 1%
anti-HLA-A2,B7 In Vivo Antibody – Low Endotoxin (BB7.6) is stable when stored at 2-8°C. Do not freeze.
Each investigator should determine their own optimal working dilution for specific applications.
Products are for research use only. Not for use in diagnostic or therapeutic procedures.